Skip to main content
AMB Express logoLink to AMB Express
. 2019 Jun 28;9:95. doi: 10.1186/s13568-019-0816-3

Biologically active metabolite(s) from haemolymph of red-headed centipede Scolopendra subspinipes possess broad spectrum antibacterial activity

Salwa Mansur Ali 1,#, Naveed Ahmed Khan 1,#, K Sagathevan 1, Ayaz Anwar 1, Ruqaiyyah Siddiqui 1,
PMCID: PMC6598926  PMID: 31254123

Abstract

The discovery of novel antimicrobials from animal species under pollution is an area untapped. Chinese red-headed centipede is one of the hardiest arthropod species commonly known for its therapeutic value in traditional Chinese medicine. Here we determined the antibacterial activity of haemolymph and tissue extracts of red-headed centipede, Scolopendra subspinipes against a panel of Gram-positive and Gram-negative bacteria. Lysates exhibited potent antibacterial activities against a broad range of bacteria tested. Chemical characterization of biologically active molecules was determined via liquid chromatography mass spectrometric analysis. From crude haemolymph extract, 12 compounds were identified including: (1) l-Homotyrosine, (2) 8-Acetoxy-4-acoren-3-one, (3) N-Undecylbenzenesulfonic acid, (4) 2-Dodecylbenzenesulfonic acid, (5) 3H-1,2-Dithiole-3-thione, (6) Acetylenedicarboxylate, (7) Albuterol, (8) Tetradecylamine, (9) Curcumenol, (10) 3-Butylidene-7-hydroxyphthalide, (11) Oleoyl Ethanolamide and (12) Docosanedioic acid. Antimicrobial activities of the identified compounds were reported against Gram-positive and Gram-negative bacteria, fungi, viruses and parasites, that possibly explain centipede’s survival in harsh and polluted environments. Further research in characterization, molecular mechanism of action and in vivo testing of active molecules is needed for the development of novel antibacterials.

Keywords: Centipede, Antibacterials, Superbugs

Introduction

Given the increasing burden of bacterial infections and multiple-drug resistant bacteria, there is an urgent need for the development of novel antimicrobials (Tacconelli et al. 2018). In the USA alone, at least two million people acquire antibiotic-resistant infections resulting in 23,000 deaths annually (CDC 2018). The rate of emergence of resistant strains is much higher than the rate of introduction of new antibiotics in the market (CDC 2018). The development of antimicrobials from natural products is of prime importance (Mérillon and Rivière 2018; Harvey et al. 2015). Notably, the majority of commercially available natural products are derived from bacteria, fungi and plants. Nearly 70% of antibiotics are derived from soil dwelling bacteria (Smith 2000) such as actinomycin (from Streptomyces antibioticus), erythromycin (from Streptomyces erythraeus), aminoglycosides (from Streptomyces and Micromonospora) etc. Likewise, the first antibiotic penicillin was isolated from fungus Penicillium notatum (Fleming 1929), cephalosporins from Acremonium species (Newton and Abraham 1955) and ascochital, pestalone, indanonaftol A are antibiotics from various fungal species (Bugni and Ireland 2004; Cueto et al. 2001). Similarly, plant and plant products containing sesquiterpenes, triterpenes, flavonoids, procyanidins are shown to possess broad spectrum antibacterial activity against Gram-positive and Gram-negative bacteria (Ahmad et al. 1994). Of note, Kingdom Animalia represents largest diversity with more than 8 million species (Census of Marine Life). Classes such as fishes, amphibians, reptiles, birds and mammals comprises a huge diversity of terrestrial, marine and aquatic fauna (Science daily 2011). Unlike plants, their exposure to polluted environments and disease causing agents is greater. Therefore, it is thought that their ability to defend against pathogenic microorganisms is relevant to humans and must be explored. For example, cockroaches thrive in polluted environments suggesting their innate ability to produce anti-infective agents (Lee et al. 2011). Also, invertebrates particularly insects are used to treat various illnesses and are common in traditional medicines (Costa-Neto 2005). Insects such as hairy arachnids, Chinese black mountain ant, honey bee and bee products, scorpions, grass hoppers, silk worms, termites etc. are believed to possess various health benefits and are used in the treatment of wound healing, pain, cough, inflammation, fever, gastrointestinal related disorders, reproductive illnesses, pneumonia, hemorrhage, diarrhea etc. (Feng et al. 2009; Srivastava et al. 2009). However, the scientific basis of their medicinal properties remains incompletely understood. Previously, we showed the presence of potent antibacterial molecules in cockroaches against methicillin resistant Staphylococcus aureus (MRSA) and neuropathogenic Escherichia coli K1 (Lee et al. 2011; Ali et al. 2016). Several molecules were identified containing isoquinoline group, chromene derivatives, thiazine groups, imidazoles, pyrrole-containing analogs, sulfonamides, furanones, and flavanones with known antibacterial properties (Ali et al. 2016). Among other species, forest centipede, Scolopendra subspinipes, (also named as Vietnamese or Chinese Red-headed centipede) is commonly used in folk medicine, for its various health benefits in the treatment of wounds, pain, inflammation, sores and tumors (Lee et al. 2017; Bajpai et al. 2017; Ding et al. 2016; Choi et al. 2008). Mainly, distributed in East Asian countries, they are large with the maximum length of 20 cm and feeds primarily on insects, arachnids and small vertebrate animals, and encounter pathogens in their natural habitat (Bush et al. 2001). They must have developed mechanisms to counter infections. Hence, we aim to determine antibacterial activity of S. subspinipes against a panel of Gram-positive and Gram-negative bacteria and to identify biological molecule(s) using liquid chromatography mass spectrometry.

Materials and methods

Bacterial cultures

Eight clinical isolates were tested in this study, among which MRSA (Malaysian Type Culture Collection MTCC 381123), Bacillus cereus (MTCC 131621) and Streptococcus pyogenes (ATCC 49399) were Gram-positive; while, Escherichia coli K1 (MTCC 710859), Pseudomonas aeruginosa (American Type Culture Collection ATCC 10145), Klebsiella pneumonia (ATCC 13883), Salmonella enterica (ATCC 14028) and Serratia marcescens (ATCC 13880) were Gram-negative. All the strains were resistant to two or more antibiotics (Table 1). A 24 h old bacterial broth culture was used for experiments as previously described (Khan et al. 2008).

Table 1.

Antibiotic susceptibility profile of bacteria used in this study

Bacteria/ID no Antibiotic susceptibility profile
amx 25 µg amc 20/10 µg cip 10 µg cst 10 µg enr 5 µg gen 10 µg lcn 15 µg nxn 10 µg tcn 30 µg sxt 1.25 + 23.75 µg
Methicillin-resistant S. aureus MTCC 381123 R R R R R S S R S R
E. coli K1 MTCC 710859 R R S S S S R R S S
S. pyogenes ATCC 49399 R R S R S S R S S I
B. cereus MTCC 131621 R R S R R S S S S S
P. aeruginosa ATCC 10145 R R S R R S R S R R
K. pneumonia ATCC 13883 R S S S R S R S R S
S. enterica ATCC 14028 S S S S S R R S I S
S. marcescens ATCC 13880 R R S R S S R S S S

Organ lysates of centipede

Wild forest centipedes (S. subspinipes) with approximate length of 18 cm were collected from forest plantation from their natural habitat and kept in a glass cage individually overnight at 30 °C with soil organic matter. 70% ethanol was used to disinfect dissection tools. Centipedes were kept at 4 °C for 15 min. The insect was immobilized by the dissection pins on the anterior and posterior end of the body in a wax tray. The head and legs were removed, and the haemolymph was collected aseptically in ethylenediamine tetraacetic acid (EDTA) containing vacutainer by inserting the sterile pipette tip at the lateral opening of the removed limb (Fig. 1). Digestive system was exposed by the vertical incision made along the midline of the body and the sample was removed aseptically. After collecting the haemolymph and gut, muscle tissue was exposed, a sample of which was aseptically removed and suspended in small volume of sterile distilled water. Protease inhibitors (serine/cysteine/metallo-proteases) were added and the samples were processed at 4 °C and gut and muscle tissue were subjected to ten cycles of freeze-thawing. Homogenization of the samples were performed aseptically with mortar and pestle, followed by sonication and cold centrifugation at 10,000g for 30 min. Next, the lysates were filtered with 0.2 μm pore size sterilized filter to avoid contamination and unwanted residual particles, and the protein concentration was determined by Bio-Rad protein assay kit. Lysates were aliquoted and stored at − 20 °C until further usage.

Fig. 1.

Fig. 1

a Dorsal view of S. subspinipes with intact body segments. b Closer view of upper body of centipede. c Internal organs of the centipede along the body cavity

Antibacterial assay

Antibacterial assays were carried out to determine bactericidal and bacteriostatic activities of haemolymph and tissue lysates of centipede as reported previously (Khan et al. 2008). A 24 h old fresh bacterial culture was adjusted to the absorbance of 0.22 at 595 nm using a spectrophotometer. Approximately 106 bacterial cells suspended in 10 μL of broth, were incubated with 100 µg/mL concentration of organ lysates or 10% haemolymph at 37 °C for 2 h. After incubation, serial dilution of reaction mixture containing bacterial cells was performed followed by plating on nutrient agar plates (Ali et al. 2016; Khan et al. 2008). Bacteria incubated in PBS/broth alone were used as negative control, however, bacteria incubated with 100 μg/mL of gentamicin were used as positive control. Percentage bactericidal/bacteriostatic activity was determined as bacteria surviving relative to the control: 100 − (cfu recovered/original inoculum × 100).

Human keratinocyte cell (HaCaT) cultures

Human keratinized skin cells (Hacat) (CLS:300493) were purchased from CLS Cell Lines Service, Germany. Cells were cultured in cell culture media comprising RPMI-1640, 10% heat-inactivated fetal bovine serum, 2 mM glutamine, 100 U penicillin/mL, 100 μg streptomycin/mL, non-essential amino acids, and vitamins as previously described (Ali et al. 2016; Khan and Siddiqui 2009). Cell cytotoxicity assays were carried out in 96-well plates by inoculating 5 × 105 HaCaT cells per well per mL followed by incubation at 37 °C with 5% CO2 for 48 h. Next, complete monolayer formation was observed microscopically prior to cytotoxicity assays.

Bacterial-mediated host cell cytopathogenecity assays

Centipede haemolymph (10%) was incubated with 106 bacterial cells at 37 °C for 2 h followed by co-incubation with approx. 2 × 106 HaCaT cells at 37 °C in a 5% CO2 incubator for 20 h. Next day, cell suspensions containing metabolites and lactate dehydrogenase enzyme (if present) were collected, centrifuged and subjected to reaction with substrate and dye (present in cytotoxicity detection kit) for 10 min and cytopathogenicity was determined by measuring absorbance of test and control wells at 495 nm. Bacterial-mediated host cell cytopathogenicity were determined and untreated bacteria incubated with human cells were used as controls (Ali et al. 2016; Khan and Siddiqui 2009). Percent cytotoxicity was determined by = (sample value − control value)/(total LDH release − control value) × 100.

Liquid chromatography–mass spectrometry (LC–MS): separation and analysis

Centipede haemolymph was tested for further chemical identity. Haemolymph was subjected for LC–MS analysis on Agilent 1290 infinity liquid chromatograph (Agilent Technologies, Wilmington, DE), coupled with an Agilent 6520 Accurate-Mass quadrupole-time of flight (Q-TOF) mass spectrometer with dual electrospray ionization source (ESI). Reverse-phase high performance liquid chromatography was used for separation of compounds, with an agilent Zorbax Eclipse XDB-C18, Narrow-Bore 2.1 × 150 mm, 3.5-micron column at 25 °C, and equilibrated with solvent A (0.1% formic acid in Milli-Q water) and solvent B (0.1% formic acid in Acetonitrile). 0.5 mL/min flow rate with a linear gradient was used as follows: 5% solvent B for 5 min, 100% solvent B for 20 min, and 100% solvent B for 25 min. The total run time was 30 min. The compounds were ionized using dual ESI + Accurate-Mass Q-TOF mass spectrometer. The ion source parameters were as follows: capillary voltage at 4000 V for positive and 3000 V for negative ion polarity. Flow rate of drying gas was 10 L/min with a fragmentor voltage of 125 V and gas temperature of 300 °C. Pressure of nebulizer gas was set at 45 psi with Quadrupole-TOF detector, while 50% MeOH + 50% Milli-Q water was used as blank after processing each sample.

Identification of compounds through Metlin database

As described, haemolymph was processed for liquid chromatography mass spectrometric analysis, in order to obtain the spectra of chromatograms determining molecular mass of the compounds in crude extract. The mass spectra of the compounds retrieved from HPLC were run against Metlin_AM_PCDL-N-170502.cdb for identification with exact homology through Agilent Mass Hunter software, while keeping in view compensation needed for charges in positive ESI MS as well as electron fragmentations, to ensure searches for the correct parent mass. Novelty determination of the identified compounds was performed on Scifinder software. However, previously reported compounds were subjected to literature search for biological activities.

Results

Centipede lysates exhibit potent antibacterial activity against broad range of bacteria

Centipede’s haemolymph was aspirated and lysates were prepared and tested against Gram-positive and Gram-negative bacteria for determination of antibacterial effects. In particular, haemolymph was remarkably active against bacterial strains tested with more than 90% growth inhibitory activities against MRSA and B. cereus, but more than 50% bacteriostatic activity against E. coli K1, K. pneumonia, S. enterica, S. marcescens and S. pyogenes. Muscle lysates exhibited more than 50% bacteriostatic activity against S. enterica, S. marcescens, P. aeruginosa and S. pyogenes (Fig. 2).

Fig. 2.

Fig. 2

Fig. 2

The crude extracts of red centipede’s haemolymph, gut and muscles were prepared and tested in antibacterial bioassays. For negative control, bacteria incubated with nutrient broth/PBS was used and for positive control bacteria incubated with 100 μg/mL of gentamicin was used. Asterisk represents P < 0.05. P values were obtained using two-sample T test and two-tailed distribution. a Represents 0% growth indicating potent bacteriostatic activity of 10% haemolymph, 100 μg/mL of muscle and gut extracts of red centipede against MRSA. b Represents cidal assay, indicating 50%, 80% and 68% viability of respective extracts against MRSA. c Represents more than 90% bacteriostatic activity of all the three extracts against B. cereus. d Also represents more than 90% bactericidal activity for all three extracts against B. cereus. e Represents 49%, 31% and 63% growth in bacteriostatic assays respectively against K. pneumoniae. f Represents 48%, 53% and 75% viability in bactericidal assays respectively against K. pneumoniae. g Represents 22%, 10% and 49% growth in bacteriostatic assays respectively against S. enterica. h Represents 55% and 78% viability for haemolymh and gut extracts however, muscle extracts was not active in bactericidal assays against S. enterica. i Represents 27%, 31% and 70% growth in bacteriostatic assays respectively against E. coli K1. j Represents 49%, 44% and 73% viability in bactericidal assays respectively against E. coli K1. k Represents nearly 50% bacteriostatic activity of all three extracts against S. marcescens. l Represents no bactericidal activity of centipede’s extracts against S. marcescens. m Represents nearly 83, 81 and 47% growth of centipede’s haemolymph, gut and muscles respectively against P. aeruginosa. n Represents no bactericidal activity of centipede’s extracts against P. aeruginosa. o Represents nearly 33, 19 and 38% growth of centipede’s haemolymph, gut and muscles respectively against S. pyogenes. p Represents 63, 50 and 51% viability of the extracts respectively against S. pyogenes. The results are representative of several experiments performed in duplicates and expressed as the mean ± standard error

Host cell cytopathogenecity assays

To determine the toxic effects of haemolymph treated bacteria against primary human keratinocytes, cytopathogenicity assays were performed. Treated and untreated bacterial cells were incubated at 37 °C for 2 h, followed by co-incubation with HaCaT monolayers at 37 °C in a 5% CO2 incubator for 20 h and lactate dehydrogenase enzyme release (cell lysis marker), was measured using a cytotoxicity detection kit. When treated with 10% haemolymph, B. cereus showed host cell death significantly reduced, from 100% to only 36% (P < 0.05). Similarly, E. coli K1 treated with haemolymph also showed significant reduction in producing host cell damage (P < 0.05). Notably, haemolymph alone produced approximately 25% host cell damage (data not shown). Overall, the treatment of bacterial cells with centipede’s haemolymph reduced bacterial-mediated host cell damage as compared to untreated bacteria (Fig. 3).

Fig. 3.

Fig. 3

The haemolymph of red centipede was aspirated and tested in cytopathogenicity assay against Human Keratinocyte HaCaT monolayers. 10% haemolymph was incubated with 106 bacterial cells for 2 h at 37 °C, followed by the co-incubation with HaCaT monolayers in 5% CO2 incubator at 37 °C for 18–20 h. Untreated bacteria incubated with HaCaT monolayers were used as control. Next day, supernatent containg lactate dehygrogenease enzyme were collected, centrifuged and determined by Rosche cytotocicity detection Kit as per guidelines. Significant reduction was observed in the cytopathogenicity caused by the pre-treated bacteria incubated with haemolymph as compared to untreated bacteria. B. cereus showed up to 36% and E. coli K1 showed up to 64% cytotoxicity to human cells when pre-treated with haemolymph in contrast to untreated bacteria which showed 100% cytopathogenicity to human cells. The results are representative of several experiments performed in duplicates and expressed as the mean ± standard error

Identification of biologically active molecule(s) in centipede haemolymph using liquid chromatography–mass spectrometry

Centipede haemolymph was subjected to LC–MS (Agilent Technologies 6520 Accurate-Mass Q-TOF mass spectrometer with dual ESI source) for qualitative analyses. Figure 4 shows spectra from negative and positive ion polarity. Compounds present in haemolymph were separated in the column on the basis of mass to charge ratio (m/z) and retention time. The data obtained from the LC–MS for haemolymph contained 48 compounds in total, out of which identity of 12 compounds was confirmed. These include, (1) l-Homotyrosine, (2) 8-Acetoxy-4-acoren-3-one, (3) N-Undecylbenzenesulfonic acid, (4) 2-Dodecylbenzenesulfonic acid, (5) 3H-1,2-Dithiole-3-thione, (6) Acetylenedicarboxylate, (7) Albuterol, (8) Tetradecylamine, (9) Curcumenol, (10) 3-Butylidene-7-hydroxyphthalide, (11) Oleoyl Ethanolamide and (12) Docosanedioic acid (Table 2). From remaining 36 compounds, limited information regarding retention time, molecular mass and formula of 23 compounds were determined, whereas for 13 compounds, only molecular mass and retention time were determined (Table 3). The 12 compounds identified from centipede haemolymph were subjected for novelty determination via Scifinder software. Interestingly, all of them were found to possess reported biological activities for their exact and homologous structures.

Fig. 4.

Fig. 4

Scolopendra subspinipes haemolymph was subjected to LC–MS (Agilent 6520 Accurate-Mass Q-TOF mass spectrometer with dual ESI source) for qualitative analyses. The compounds were separated based on m/z ratio and retention time in the column. The data obtained from the LC–MS for haemolymph contained numerous peaks, out of which 12 compounds have been detected with full identity and molecular structure, however, 36 compounds were detected with the limited information of only molecular mass and retention time in the column

Table 2.

Compounds identified from the red centipede haemolymph

No. Compound Formula Structure Reported activity
1 l-Homotyrosine C10 H13 N O3 graphic file with name 13568_2019_816_Stra_HTML.gif

Exact structure: epithelial sodium channel blocker activity (Johnson 2015), antibacterial activity against Pseudomonas aeruginosa by inhibiting bacterial 4-hydroxyphenylpyruvate dioxygenase (Pascal et al. 1985), antifungal activity against Candida albicans and Candida glabrata by the inhibition of β-1,3-glucan synthesis (Klein et al. 2000; Zambias et al. 1992), act as matriptase inhibitors (Maiwald et al. 2016), antitumor activity (Ali et al. 2001), act as coagulation factor Xa inhibitors for treatment of cardiovascular diseases and thromboembolic events (Stürzebecher et al. 2015), antidiabetic activity (Bigge et al. 2003)

Similar structure: antibacterial activity against Staphylococcus aureus (Or 1997), antifungal activity against Candida species (Hammond et al. 1992), antiprotozoal activity against Trypanosoma b. rhodesiense (Mehner et al. 2008), anticancer activity against HT-29 and HCT-116 colorectal cancer cells (Ooi et al. 2010; Mehner et al. 2008), used for the treatment of hyperlipidemia by cholesterol absorption inhibitory activity (Alenfalk et al. 2005), anti-diabetic activity (Bigge et al. 2003), used for the treatment of autoimmune disorders (Surolia et al. 2014)

2 8-Acetoxy-4-acoren-3-one C17 H26 O3 graphic file with name 13568_2019_816_Strb_HTML.gif

Exact structure: this compound is the component of Acorus calamus (sweet flag) commonly found in spices (hmdb.ca), used for the treatment of epilepsy, amnesia and insomnia (Zhang et al. 2015), anti-germination activity (Nawamaki and Kuroyanagi 1996)

Similar structure: growth inhibitory activity against Staphylococcus aureus, Staphylococcus epidermidis, Bacillus cereus, and Escherichia coli (Chuysinuan et al. 2019), antifungal activity against plant fungal pathogen Pythium myriotylum (Liu et al. 2016), Phytophthora capsici and Pythium myriotylum (Liu et al. 2015), anti-cancer activity against prostate carcinoma and human neuroblastoma cells (Wang et al. 2014), cytotoxic activity against human gastric cancer (BGC-823 cells), cervical cancer (Hela) and human alveolar basal epithelial cells (A549 cells) (Xu et al. 2014), pesticidal activity (Goldblum and Warren 2018)

3 N-Undecylbenzenesulfonic acid C17 H28 O3 S graphic file with name 13568_2019_816_Strc_HTML.gif

Exact structure: fungicidal activity against Alternaria alternata, Chondrostereum purpureum, Phytophthora cactorum and P. infestans (Komorowska-kulik et al. 1998), possess detergent property (Petrov et al. 1958; Matsunaga et al. 1996)

Similar structure: antibacterial activity against Staphylococcus aureus, Bacillus subtilis, Escherichia coli and Klebsiella pneumonia and antifungal activity against Aspergillus fumigatus (Migahed et al. 2017), anti-tubercular activity against Mycobacterium tuberculosis H37Rv (Tanwar et al. 2016), pesticidal activity (Ichihashi and Okamura 2017; Hatamoto et al. 2016), fungicidal and herbicidal activity (Baba et al. 2014), act as UCH-L1 inhibitor useful for the treatment of cancer, Alzheimer disease and Parkinson disease (Lee et al. 2013), anticancer activity against human colon adenocarcinoma (Caco-2 cell line) (Rojewska et al. 2013), useful for the treatment of cancer and neurodegenerative disease (Lee et al. 2014)

4 2-Dodecylbenzenesulfonic acid C18 H30 O3 S graphic file with name 13568_2019_816_Strd_HTML.gif

Exact structure: act as agrochemical fungicides against Venturia inaequalis, Botrytis cinerea, Erysiphe graminis, Phytophthora infestans, and Puccinia recondita (Ihori et al. 2018), act as AKT PH domain inhibitors hence useful for the treatment of cancer (Ahad et al. 2011)

Similar structure: antibacterial activity against Staphylococcus aureus, Bacillus subtilis, Escherichia coli and Klebsiella pneumonia and antifungal activity against Aspergillus fumigatus (Migahed et al. 2017), pesticidal activity (Ichihashi and Okamura 2017; Hatamoto et al. 2016), anti-tubercular activity against Mycobacterium tuberculosis H37Rv (Tanwar et al. 2016), act as sitagliptin (anti-diabetic agent) intermediates (Casar and Stavber 2014)

5 3H-1,2-Dithiole-3-thione C3 H2 S3 graphic file with name 13568_2019_816_Stre_HTML.gif

Exact structure: commonly found in brassica (Human Metabolome Database), neuroprotective effects against PC12 (pheochromocytoma of the rat adrenal medulla) cells (Zhang et al. 2018a, b), used for the treatment of ischemic stroke and possess antioxidant and anti-inflammatory activity (Kuo et al. 2017), neurodegenerative activity (Brown et al. 2014), antiviral activity against human papilloma virus (Preston and Murphy 2015), antifungal activity against Candida species (Giannini et al. 2004), act as chemoprotective agent against cancer (Kwak et al. 2001), used for the treatment of autoimmune encephalomyelitis (Kuo et al. 2016)

Similar structure: protective effects against Alzheimer’s disease (Wang et al. 2017a, b), antioxidant activity (Koo et al. 2012), used to prevent and treat a disease caused by over activity of a liver X receptor α (LXR α) (Kim et al. 2016), used for the treatment of skin pigmentation disorders (Commo and Michard 2009), neuroprotective activity (Jia et al. 2009), act as cancer preventive agent (Tran et al. 2009), antioxidant activity (Perez-Leal et al. 2017), anti-inflammatory and anti-neurodegenerative activity (Jarrott and Williams 2016)

6 Acetylenedicarboxylate C4 H2 O4 graphic file with name 13568_2019_816_Strf_HTML.gif

Exact structure: act as succinate receptor agonists (Geubelle et al. 2017), act as inhibitors of bacterial urease released by Helicobacter pylori and Proteus mirabilis (Macegoniuk et al. 2017), used in the synthesis of quinoline and pyrroloquinoline derivative with anticancer activity against MCF-7 (breast cancer), HepG2 (liver carcinoma) and HCT (human colon cancer) cells (Mohamede et al. 2015), used in the synthesis of anticancer compounds against human gastric carcinoma N87 cells (Zhao et al. 2016), involved in the synthesis of anti-giardia and anti-HIV agent (Al-Masoudi and Abbas 2016), involved in the synthesis of alpha-glucosidase inhibitors (Hyun et al. 2014)

Similar structure: antibacterial activity against Gram-negative bacteria such as Pseudomonas aeruginosa and Escherichia coli (Balkovec et al. 2017), involved in the synthesis of p53 inhibitors as anti-cancer and anti-inflammatory agent (Feder et al. 2015), involved in the preparation of amanita toxins which are effective in abnormal cell growth, proliferative disorder, neuronal disorders, immunological disorders, inflammatory disorders, autoimmune disorders, destructive disorders, bone disorder, infectious disease, neurodegenerative disorder, pancreatitis or kidney disease in a mammal (Zhao et al. 2017)

7 Albuterol C13 H21 N O3 graphic file with name 13568_2019_816_Strg_HTML.gif

Exact structure: therapeutic agent for lymphedema (Hirata et al. 2018), used in the synthesis of anticancer agent against gastric carcinoma (Zhao et al. 2018), antidepressant activity (Avram et al. 2018), anti-inflammatory and anti-asthmatic effects (Lee et al. 2016; Hakonarson et al. 2018), used to treat cardiovascular diseases (Wang et al. 2018a, b, c), anti-diabetic activity (Pelcman and Bengtsson 2018)

Similar structure: anti-epileptic activity (Stewart et al. 2018), anti-inflammatory and anti-asthmatic effects (Alvarez-Aguilar et al. 2017), used to treat Parkinson’s disease (Scherzer 2018), used for the treatment of hypoxemia and dyspnea (Martin 2018), anti-cancer activity (Weinstein et al. 2018), used to treat cardiovascular diseases (Wang et al. 2018a, b, c)

8 Tetradecylamine C14 H31 N graphic file with name 13568_2019_816_Strh_HTML.gif

Exact structure: bactericidal activity against Staphylococcus aureus and Escherichia coli (Niu et al. 2018; Savage Paul 2017), pesticidal activity (Park et al. 2018), anti-inflammatory activity (Wrasidlo and Natala 2018), antifungal activity against Candida and Aspergillus species by inhibiting ergosterol synthesis (Chandrika, et al. 2018; Garneau-Tsodikova et al. 2018), used as a component in traditional Chinese medicine for the treatment of Coronary heart disease complicated with depression (Zhang et al. 2018a, b)

Similar structure: antibacterial activity against Escherichia coli (Wang et al. 2018a, b, c), anticancer activity against bladder cancer T-24 cells (Wu et al. 2017), involved in the synthesis of antimycobacterial agent (Vosátka et al. 2018); anti-tubercular activity (de Castro et al. 2018), anti-inflammatory activity (Wrasidlo and Natala 2018)

9 Curcumenol C15 H22 O2 graphic file with name 13568_2019_816_Stri_HTML.gif

Exact structure: anti-inflammatory activity (Lee et al. 2019), antistroke agent with anti-inflammatory and cytotoxic activity for sepsis and leukemia, this compound is present in Curcuma longa (Turmeric) (Gupta et al. 2018), anti-proliferative activity against human gastric cancer cells (Jung et al. 2018), antibacterial activity against Proteus mirabilis, Staphylococcus aureus and antifungal activity against Fusarium oxysporum (Kacem et al. 2016)

Similar structure: anti-skin inflammation activity (Lim et al. 2018), neuroprotective activity (Xu et al. 2018), anticancer activity against nasopharyngeal carcinoma cells (Wang et al. 2018a, b), larvicidal activity against Aedes aegypti larvae (Sofian et al. 2017), cytotoxic activity against human prostate carcinoma cells, human skin fibroblasts (HSF) and human melanoma cells (Stojakowska et al. 2019), antileukemic activities against the KG1a and Molt4 cell lines (Anuchapreeda et al. 2018), anti-fungal activity against C. albicans (Li et al. 2017), antioxidant, anti-inflammatory, anti-cancer, and anti-diabetic activity (Hamidpour et al. 2015), antimicrobial activity against Klebsiella pneumonia, Staphylococcus aureus, Salmonella enterica, Escherichia coli, Pseudomonas aeruginosa, Proteus vulgaris, and fungus Pichia guilliermondii and Candida albicans (Kharkwala et al. 2017)

10 3-Butylidene-7-hydroxyphthalide C12 H12 O3 graphic file with name 13568_2019_816_Strj_HTML.gif

Exact structure: found in the roots of Angelica sinensis (AS) (Deng et al. 2006), anti-inflammatory activity (Tran et al. 2018), act as synergistic calcium antagonists for the treatment of coronary heart disease (Lei et al. 2018), cytotoxic activity against MCF-7 (breast cancer), NCI-H187 (lung cancer) and KB cells (Wisetsai et al. 2018), act as pancreatic lipase inhibitor for treatment of obesity (Mo et al. 2016), used for the treatment of peptic ulcer (Chung et al. 2005), used for the treatment and prevention of diabetes mellitus (D'orazio et al. 2007)

Similar structure: free radical scavenging activity (Adil et al. 2018), active component of Angelica sinensis (AS) herb, used as the blood-nourishing tonic (Chen et al. 2017), anti-inflammatory activity (Tran et al. 2018), antioxidant and antibacterial activity against Bacillus subtilis, Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, Klebseilla pneumonia, Agrobacterium tumefaciens and antifungal activity against Candida albicans, Mucor sp., Aspergillus flavus, Penicilium expansum (Ksouri et al. 2017), neuroprotective effect on PC12 cells (Lu-Si et al. 2017), used to treat bone diseases (Wang et al. 2017a, b), prevents cancer by increase the oxygen release efficiency of Hb (Wang and Chen 2017), neuroprotective and anticancer effects against lung (A549), human colon carcinoma (HCT-8), and hepatocarcinoma (HepG2) cancer cell (Gong et al. 2016)

11 Oleoyl ethanolamide C20 H39 N O2 graphic file with name 13568_2019_816_Strk_HTML.gif

Exact structure: endogenous peroxisome proliferator-activated receptor alpha (PPAR-α) agonist (Gaetani et al. 2003), antitussive activity (Wortley et al. 2017), anti-inflammatory activity (Toguri et al. 2018), used to treat post-traumatic stress disorder by fatty acid amide hydrolase (FAAH) inhibition (Danandeh et al. 2018), useful in the treatment of neurological disorders (Pandey et al. 2018), anti-nausea effect (Rock et al. 2017), analgesic activity (Zubrzycki et al. 2017), anticancer activity against colon cancer cells (Pagano et al. 2017)

Similar structure: anti-inflammatory and pain-relieving effects (Britti et al. 2017), useful in the treatment of inflammatory and neurodegenerative disorders (Barbierato et al. 2018), anticancer activity against colon cancer cell growth (de Cedrón et al. 2018), beneficial in the treatment of HIV-1 associated neurocognitive disorders (HAND) (Hermes et al. 2018), anticancer activity against endometrial cancer (Fonseca et al. 2018), useful in the treatment of intestinal barrier dysfunction (Antón et al. 2018)

12 Docosanedioic acid C22 H42 O4 graphic file with name 13568_2019_816_Strl_HTML.gif

Exact structure: plant metabolite with antifungal activity against Candida albicans, Cryptococcus neoformans, Aspergillus fumigatus and dermatophyte Trichophyton rubrum (Bierer et al. 1995; Bierer et al. 1998), anti-HIV activity (Brinkworth and Bairlie 1992), act as bivalent histamine H2 receptor (H2R) agonists (Birnkammer et al. 2012), synthesis study (Frost et al. 2010), anti-cancer and anti-inflammatory activity (Gao et al. 2013)

Similar structure: antioxidant activity (Kaneria et al. 2018), skin pigmenting activity (Giuliani et al. 2015), antimalarial activity (Baba et al. 2015), deodorant component (Sato 2016), involved in the treatment of disorders including obesity and diabetes (Just et al. 2016), cosmetic component (Nomura et al. 2016)

Table 3.

Compounds identified in the haemolymph of red-headed centipede

Compound label Retention time Molecular mass Molecular formula
Cpd 1 0.546 244.90629 C3 H Cl2 N3 O4 S
Cpd 2 0.595 147.97314 ND
Cpd 3 14.311 267.11138 C13 H17 N O5
Cpd 4 18.808 340.20795 C19 H32 O3 S
Cpd 5 19.979 117.93689 ND
Cpd 6 20.119 845.95569 ND
Cpd 7 20.256 232.95286 ND
Cpd 8 20.309 135.90438 ND
Cpd 9 20.316 101.94352 ND
Cpd 10 20.329 145.93312 C4 H2 S3
Cpd 11 20.393 983.99919 ND
Cpd 12 20.484 230.91116 ND
Cpd 13 20.485 176.99131 C4 H3 N O7
Cpd 14 20.486 198.9733 C10 H N O2 S
Cpd 15 20.502 62.99858 ND
Cpd 16 20.533 201.86891 ND
Cpd 17 20.582 227.98881 C8 H4 O8
Cpd 18 20.942 1034.9965 ND
Cpd 19 0.554 161.0228 C7 H3 N3 O2
Cpd 20 0.586 63.00717 ND
Cpd 21 0.627 161.10154 C3 H11 N7 O
Cpd 22 0.84 203.1128 C5 H13 N7 O2
Cpd 23 12.338 227.18775 C13 H25 N O2
Cpd 24 14.833 295.21517 C17 H29 N O3
Cpd 25 15.584 346.24091 C16 H34 N4 O2 S
Cpd 26 16.695 524.3939 C28 H52 N4 O5
Cpd 27 16.72 56.06329 C4 H8
Cpd 28 16.752 148.01597 C8 H4 O3
Cpd 29 16.759 480.36669 C26 H48 N4 O4
Cpd 30 16.821 436.34066 C23 H48 O7
Cpd 31 16.875 392.31449 C22 H40 N4 O2
Cpd 32 18.324 386.27256 C27 H34 N2
Cpd 33 20.509 610.16105 C37 H27 Cl N4 O S
Cpd 34 21.305 701.20692 C44 H32 Cl N3 O4
Cpd 35 22.174 662.44722 C33 H58 N8 O6
Cpd 36 22.316 775.22523 ND

ND not determined

Discussion

Development of robust antimicrobials from novel sources is the current need to counter drug resistant pathogens (Challinor and Bode 2015; Harvey et al. 2015). Most common sources of antimicrobials are bacteria, fungi, plant and plant products that have been used widely in modern medicine (Abraham et al. 1953; Wagman 1980; Negi et al. 1999). In contrast, discovery of antimicrobials from animal sources is an area explored superficially. This is despite the fact that animals particularly invertebrates such as cockroaches, ants, silk worms, scorpions and tarantulas have been used in traditional medicine for centuries (Costa-Neto 2005). For example, larval therapy is used widely to cure non-healing wounds. This involves, the application of mature blow fly larvae belonging to Sarconesiopsis genus on an open wound, resulting in the secretion of antimicrobial peptides and metabolites (Diaz-Roa et al. 2018). Maggot debridement therapy is effective to cure severe necrotizing fasciitis, caused by more than one type of bacteria such as MRSA, Streptococcus pyogenes, enterococci, E. coli, P. aeruginosa, Clostridium and Bacteroides species (Maya et al. 2014). Maggot debridement therapy is useful in patients suffering from necrotizing fasciitis with an underlying disease who cannot be subjected to surgical procedures such as diabetic patients (Dunn et al. 2002). Other studies showed that application of sterile larvae belonging to genus Lucilia sericata, Protophormia terraenovae, Sarconesiopsis magellanica secretes antimicrobial molecules/peptides such as as p-hydroxybenzoic acid, p-hydroxyphenylacetic acid, dioxopiperazine proline, seraticin, defensins, cecropins, diptericins and proline-rich peptides with potent anti-biofilm and wound healing properties (Nigam et al. 2010; Chernysh et al. 2018). Similarly, arthropods such as wild centipedes have been used in traditional Chinese medicine, often used to treat various illnesses such as seizures, apoplexy, stroke induced hemiplegia, diphtheria, tuberculosis, pyocutaneous disease etc. (Moon et al. 1996; Undheim and King 2011). In Korea, crushed centipede is used to treat back pains, sores and furuncles (Douglas 2014). Recent studies also highlight its broad range of antimicrobial activity against various pathogens. For example, S. subspinipes mutilans exhibited antifungal activity by membrane permeabilization in Candida albicans (Choi et al. 2013). Similarly, antimicrobial activity of the peptide lacrain, isolated from body extract of S. viridicornis showed strong bactericidal activity against Gram-negative bacteria (Chaparro and Da Silva Junior 2016). 3,8-Dihydroxyquinoline also known as jineol, isolated from S. subspinipes mutilans showed antibacterial activity by altering the release of potassium ions from food borne pathogenic strains of E. coli O157:H7 and S. aureus KCTC-1621 (Bajpai et al. 2017). Several other AMPs such as Scolopendrasin I, V, VII are known to possess broad range of antimicrobial activities against drug resistant pathogens (Wenhua et al. 2006; Peng et al. 2010). For the first time, here we determined the antibacterial activity of the haemolymph/organ lysates of red-headed centipede S. subspinipes, with molecular identification of biological components using LC/MS. Our findings suggest that haemolymph and tissue extract of centipede exhibited antibacterial activity against Gram-positive and Gram-negative bacteria. Haemolymph subjected to chemical characterization indicated the identification of 12 compounds with reported biological activities against Gram-positive and Gram-negative bacteria, fungi, viruses and parasites (Pascal et al. 1985; Komorowska-kulik et al. 1998; Niu et al. 2018; Bierer et al. 1998; Baba et al. 2015). For example, compounds 1, 3, 4, 5, 6, 8, 9 and 12 possess antimicrobial activity against a broad range of microorganisms such as S. aureus, P. aeruginosa, P. mirabilis E. coli, H. pylori, Aspergillus species, Candida species, F. oxysporum, C. neoformans, dermatophyte T. rubrum, A. alternata, C. purpureum, P. cactorum, P. infestans, V. inaequalis, B. cinerea, E. graminis, P. recondite, Human Papilloma virus, HIV and parasite Giardia.

Moreover, compounds 1, 4, 5, 6, 7, 9, 10, 11, 12 possess anticancer activity against colon cancer cells, MCF-(breast cancer), NCI-H187 (lung cancer) and KB cells, human gastric cancer cells, HepG2 (Liver carcinoma) cells (Pagano et al. 2017; Wisetsai et al. 2018; Jung et al. 2018; Ali et al. 2001; Bigge et al. 2003; Kuo et al. 2016; Pelcman and Bengtsson 2018; Lee et al. 2016; Hakonarson et al. 2018) (Table 2).

Interestingly, some of the compounds identified also possess antidiabetic, anti-neurodegenerative, antioxidant, antiepileptic and anticancer activities (Bigge et al. 2003; Wisetsai et al. 2018; Gong et al. 2016). Identified compounds contain furan, tyrosine, thione, albuterol, amines, curcumenol and pthalide moieties, potentially responsible for biological activities. Notably, compounds 2, 5, 9, 10 and 12 are phytochemicals with antibacterial, antifungal, anti-inflammatory, anticancer and analgesic properties (Giannini et al. 2004; Gupta et al. 2018; Tran et al. 2018; Kacem et al. 2016; Brinkworth and Bairlie 1992). Biological significance of these compounds are due to their distinct features and structural arrangement of the functional groups. For example, sulfides and disulfides in cpd 5 are active ingredients. Sulphur has its characteristic property and is an essential component in antibiotics such as sulphonamides (Mitchard 1988). Curcumenol cpd 9, containing tetrahydrofuran is an active five-membered oxygen heterocyclic compound, commonly found in natural products, mainly responsible for their antibacterial activity (Keglevich 2015). Phthalides and fatty acids present in cpd 10 and 12 are also well known for their broad spectrum activities such as antiinflammatory, antimicrobial and anticancer activities (Bierer et al. 1995; Gao et al. 2013; Wisetsai et al. 2018). Notably, 36 compounds were not identified in this study. These are also of potential interest and could represent novel antibacterials (Table 3).

In summary, the discovery of natural antibiotic molecules from animals/invertebrates, exposed to the environmental wastes and pollutants in their natural habitat is a fascinating though unexploited area of research. Hence, it is anticipated that the antibiotics from natural sources are minimal or less toxic for biological system as compared to synthetic antibiotic molecules. Further identification, in vivo testing and clinical trials of potentially active metabolites can act as a milestone for the synthesis and development of novel drug leads.

Acknowledgements

Authors are grateful to N. Akbar for providing technical assistance.

Abbreviations

MRSA

methicillin resistant Staphylococcus aureus

MTCC

Malaysian Type Culture Collection

ATCC

American Type Culture Collection

EDTA

ethylenediamine tetraacetic acid

cfu

colony forming units

Hacat

human keratinized skin cells

RPMI

Roswell Park Memorial Institute

LDH

lactate dehydrogenase

LC–MS

liquid chromatography–mass spectrometry

Q-TOF

quadrupole-time of flight

ESI

electrospray ionization

Authors’ contributions

NAK and RS conceived the study. SA and KS sourced the invertebrates and carried out all dissections. SA carried out all experiments under the supervision of RS and NAK. SA carried out LC/MS analyses under the supervision of AA. SA prepared the first draft of the manuscript under the supervision of RS. NAK and RS corrected the manuscript. All authors read and approved the final manuscript.

Funding

This study was funded by the FRGS and Sunway University, Malaysia.

Availability of data and materials

All the data analysed in this study are included in this article.

Ethics approval and consent to participate

This article does not contain any studies with human participants or vertebrates performed by any of the authors.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Salwa Mansur Ali and Naveed Ahmed Khan contributed equally to this manuscript

Contributor Information

Salwa Mansur Ali, Email: salwamansurali@yahoo.com.

Naveed Ahmed Khan, Email: naveed5438@gmail.com.

K. Sagathevan, Email: sagatk@sunway.edu.my

Ruqaiyyah Siddiqui, Phone: 60-(0)3-7491-8622, Email: ruqaiyyahs@sunway.edu.my.

References

  1. Abraham EP, Newton GGF, Crawford K, Burton HS, Hale CW. Cephalosporin N: a new type of penicillin. Nature. 1953;171:343. doi: 10.1038/171343a0. [DOI] [PubMed] [Google Scholar]
  2. Adil M, Ren X, Kang DI, Jeong BR. Effect of explant type and plant growth regulators on callus induction, growth and secondary metabolites production in Cnidium officinale Makino. Mol Biol Rep. 2018;45:1919–1927. doi: 10.1007/s11033-018-4340-3. [DOI] [PubMed] [Google Scholar]
  3. Ahad AM, Zuohe S, Du-Cuny L, Moses SA, Zhou LL, Zhang S, Powis G, Meuillet EJ, Mash EA. Development of sulfonamide AKT PH domain inhibitors. Bioorg Med Chem. 2011;19:2046–2054. doi: 10.1016/j.bmc.2011.01.049. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Ahmad VU, Ahmad WU, Aliya R, Baqai FT, Iqbal S, Khatoon R, Mohammad FV, Noorwala M, Perveen S, Pervez A, Saba N. New natural products from terrestrial medicinal plants and marine algae. Pure Appl Chem. 1994;66:2311–2314. doi: 10.1351/pac199466102311. [DOI] [Google Scholar]
  5. Alenfalk S, Dahlstroem M, Hunegnaw F, Karlsson S, Lemurell M, Lindqvist AM, Skjaeret T, Starke I (2005) Preparation of diphenylazetidinone amino acid derivatives having cholesterol absorption inhibitory activity. PCT Int Appl WO 2005061452 A1 20050707
  6. Ali S, Tang HY, Mayhew E, Janoff AB (2001) Preparation of ceramide derivatives for pharmaceutical use as antitumor agents. PCT Int Appl WO 2001072701 A1 20011004
  7. Ali SM, Siddiqui R, Ong SK, Shah MR, Anwar A, Heard PJ, Khan NA. Identification and characterization of antibacterial compound (s) of cockroaches (Periplaneta americana) Appl Microbiol Biotechnol. 2016;101:253–286. doi: 10.1007/s00253-016-7872-2. [DOI] [PubMed] [Google Scholar]
  8. Al-Masoudi NA, Abbas ZA. Synthesis and biological activity of new metronidazole derivatives. Monatsh Chem. 2016;147:383–390. doi: 10.1007/s00706-015-1612-7. [DOI] [Google Scholar]
  9. Alvarez-Aguilar A, Rosales-Hernández FJ, Francisco J. Quantum analysis of the interaction of Salbutamol and Nt. World J Pharm Pharm Sci. 2017;6:62–70. [Google Scholar]
  10. Antón M, Rodríguez-González A, Ballesta A, González N, Del Pozo A, de Fonseca FR, Gómez-Lus ML, Leza JC, García-Bueno B, Caso JR, Orio L. Alcohol binge disrupts the rat intestinal barrier: the partial protective role of oleoylethanolamide. Br J Pharmacol. 2018;175:4464–4479. doi: 10.1111/bph.14501. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Anuchapreeda S, Khumpirapang N, Rupitiwiriya K, Tho-iam L, Saiai A, Okonogi S, Usuki T. Cytotoxicity and inhibition of leukemic cell proliferation by sesquiterpenes from rhizomes of Mah-Lueang (Curcuma cf. viridiflora Roxb.) Bioorg Med Chem Lett. 2018;28:410–414. doi: 10.1016/j.bmcl.2017.12.029. [DOI] [PubMed] [Google Scholar]
  12. Avram S, Milac AL, Mernea M, Alexandrescu IM, Borcan LC, Borcan F. Predicted mechanism of antiasthmatic drugs in depression based on their interaction with SERT and 5-HT1A receptors. Curr Enzyme Inhib. 2018;14:51–60. doi: 10.2174/1573408013666170706102442. [DOI] [Google Scholar]
  13. Baba K, Kuroki N, Kobayashi M, Hakuno F (2014) Pyrazinecarboxamide derivative or salt comprising agricultural and horticultural fungicide compositions and methods of use thereof. Jpn Kokai Tokkyo Koho JP 2014224067 A 20141204
  14. Baba MS, Zin NM, Hassan ZAA, Latip J, Pethick F, Hunter IS, Edrada-Ebel R, Herron PR. In vivo antimalarial activity of the endophytic actinobacteria, Streptomyces SUK 10. J Microbiol. 2015;53:847–855. doi: 10.1007/s12275-015-5076-6. [DOI] [PubMed] [Google Scholar]
  15. Bajpai VK, Shukla S, Paek WK, Lim J, Kumar P, Na M. Antibacterial action of jineol isolated from Scolopendra subspinipes mutilans against selected foodborne pathogens. Front Microbiol. 2017;8:552. doi: 10.3389/fmicb.2017.00552. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Balkovec JM, Bensen DC, Blizzard T, Borchardt Allen, Brady TP, Chen ZY, Do QT, Jiang W, Lam T, Locke JB, Noncovich A (2017) Compositions and methods for the treatment of bacterial infections. PCT Int Appl WO 2017218922 A2 20171221
  17. Barbierato M, Skaper SD, Facci L. Neurotrophic factors. New York: Humana Press; 2018. Oligodendrocyte progenitor cell cultures: a model to screen neurotrophic compounds for myelin repair; pp. 155–166. [DOI] [PubMed] [Google Scholar]
  18. Bierer DE, Gerber RE, Jolad SD, Ubillas RP, Randle J, Nauka E, Latour J, Dener JM, Fort DM. Isolation, structure elucidation, and synthesis of irlbacholine, 1, 22-Bis [[[2-(trimethylammonium) ethoxy] phosphinyl] oxy] docosane: a novel antifungal plant metabolite from Irlbachia alata and Anthocleista djalonensis. J Org Chem. 1995;60:7022–7026. doi: 10.1021/jo00126a066. [DOI] [Google Scholar]
  19. Bierer DE, Dener JM, Truong TV (1998) Process for the preparation of mono-and bis (phosphocholine) derivatives which have antifungal activity. U.S. Patent 5,811,568
  20. Bigge CF, Bridges AJ, Casimiro-Garcia A, Fakhoury SA, Lee HT, Reed JE, Schaum RP, Schlosser KM, Sexton KE, Zhou H (2003) Preparation of azoles as oral antidiabetic agents. PCT Int Appl WO 2003018553 A1 20030306
  21. Birnkammer T, Spickenreither A, Brunskole I, Lopuch M, Kagermeier N, Bernhardt G, Dove S, Seifert R, Elz S, Buschauer A. The bivalent ligand approach leads to highly potent and selective acylguanidine-type histamine H2 receptor agonists. J Med Chem. 2012;55:1147–1160. doi: 10.1021/jm201128q. [DOI] [PubMed] [Google Scholar]
  22. Brinkworth RI, Bairlie DP. Non-peptidic anti-AIDS agents: inhibition of HIV-1 proteinase by disulfonates. Biochem Biophys Res Commun. 1992;188:624–630. doi: 10.1016/0006-291X(92)91102-V. [DOI] [PubMed] [Google Scholar]
  23. Britti D, Crupi R, Impellizzeri D, Gugliandolo E, Fusco R, Schievano C, Morittu VM, Evangelista M, Di Paola R, Cuzzocrea S. A novel composite formulation of palmitoylethanolamide and quercetin decreases inflammation and relieves pain in inflammatory and osteoarthritic pain models. BMC Vet Res. 2017;13:229. doi: 10.1186/s12917-017-1151-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Brown DA, Betharia S, Yen JH, Tran Q, Mistry H, Smith K. Synthesis and structure–activity relationships study of dithiolethiones as inducers of glutathione in the SH-SY5Y neuroblastoma cell line. Bioorg Med Chem Lett. 2014;24:5829–5831. doi: 10.1016/j.bmcl.2014.10.005. [DOI] [PubMed] [Google Scholar]
  25. Bugni TS, Ireland CM. Marine-derived fungi: a chemically and biologically diverse group of microorganisms. Nat Prod Rep. 2004;21:143–163. doi: 10.1039/b301926h. [DOI] [PubMed] [Google Scholar]
  26. Bush SP, King BO, Norris RL, Stockwell SA. Centipede envenomation. Wilderness Environ Med. 2001;12:93–99. doi: 10.1580/1080-6032(2001)012[0093:CE]2.0.CO;2. [DOI] [PubMed] [Google Scholar]
  27. Casar Z, Stavber G (2014) Preparation of sitagliptin intermediates U.S. Pat Appl Publ US 20140187558 A1 20140703
  28. Centers for Disease Control and Prevention (2018) Antibiotic/Antimicrobial resistance. https://www.cdc.gov/drugresistance/about.html. Accessed 11 June 2019
  29. Challinor VL, Bode HB. Bioactive natural products from novel microbial sources. Ann N Y Acad Sci. 2015;1354:82–97. doi: 10.1111/nyas.12954. [DOI] [PubMed] [Google Scholar]
  30. Chandrika NT, Shrestha SK, Ngo HX, Howard KC, Garneau-Tsodikova S. Novel fluconazole derivatives with promising antifungal activity. Bioorg Med Chem. 2018;26:573–580. doi: 10.1016/j.bmc.2017.12.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Chaparro E, Da Silva Junior PI. Lacrain: the first antimicrobial peptide from the body extract of the Brazilian centipede Scolopendra viridicornis. Int J Antimicrob Agents. 2016;48:277–285. doi: 10.1016/j.ijantimicag.2016.05.015. [DOI] [PubMed] [Google Scholar]
  32. Chen WR, Yu Y, Zulfajri M, Lin PC, Wang CC. Phthalide derivatives from Angelica Sinensis decrease hemoglobin oxygen affinity: a new allosteric-modulating mechanism and potential use as 2,3-BPG functional substitutes. Sci Rep. 2017;7:5504. doi: 10.1038/s41598-017-04554-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Chernysh S, Gordya N, Tulin D, Yakovlev A. Biofilm infections between Scylla and Charybdis: interplay of host antimicrobial peptides and antibiotics. Infect Drug Resist. 2018;11:501. doi: 10.2147/IDR.S157847. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Choi YK, Lee DD, Kim GW, Koo BS. Antioxidative effects of Scolopendra subspinipes. J Orient Neuropsychiatry. 2008;19:129–142. [Google Scholar]
  35. Choi H, Hwang JS, Lee DG. Antifungal effect and pore-forming action of lactoferricin B like peptide derived from centipede Scolopendra subspinipes mutilans. Biochim Biophys Acta Biomembr. 2013;1828:2745–2750. doi: 10.1016/j.bbamem.2013.07.021. [DOI] [PubMed] [Google Scholar]
  36. Chung YJ, Kim YC, Lee KH, Namgung MA (2005) Peptic ulcer treating agent inhibiting activity of proton pump to inhibit secretion of gastric acid. Repub Korean Kongkae Taeho Kongbo KR 2005023998 A 20050310
  37. Chuysinuan P, Chimnoi N, Reuk-Ngam N, Khlaychan P, Makarasen A, Wetprasit N, Dechtrirat D, Supaphol P, Techasakul S. Development of gelatin hydrogel pads incorporated with Eupatorium adenophorum essential oil as antibacterial wound dressing. Polym Bull. 2019;76:701–724. doi: 10.1007/s00289-018-2395-x. [DOI] [Google Scholar]
  38. Commo S, Michard Q (2009) Use of dithiolethione derivatives for the treatment of skin pigmentation disorders. Fr Demande FR 2925336 A1 20090626
  39. Costa-Neto EM. Entomotherapy, or the medicinal use of insects. J Ethnobiol. 2005;25:93–115. doi: 10.2993/0278-0771(2005)25[93:EOTMUO]2.0.CO;2. [DOI] [Google Scholar]
  40. Cueto M, Jensen PR, Kauffman C, Fenical W, Lobkovsky E, Clardy J. Pestalone, a new antibiotic produced by a marine fungus in response to bacterial challenge. J Nat Prod. 2001;64:1444–1446. doi: 10.1021/np0102713. [DOI] [PubMed] [Google Scholar]
  41. Danandeh A, Vozella V, Lim J, Oveisi F, Ramirez GL, Mears D, Wynn G, Piomelli D. Effects of fatty acid amide hydrolase inhibitor URB597 in a rat model of trauma-induced long-term anxiety. Psychopharmacology. 2018;235:3211–3221. doi: 10.1007/s00213-018-5020-7. [DOI] [PubMed] [Google Scholar]
  42. De Castro PP, Campos DL, Pavan FR, Amarante GW. Dual-protected amino acid derivatives as new antitubercular agents. Chem Biol Drug Des. 2018;92:1576–1580. doi: 10.1111/cbdd.13315. [DOI] [PubMed] [Google Scholar]
  43. De Cedrón MG, Vargas T, Madrona A, Jiménez A, Pérez-Pérez MJ, Quintela JC, Reglero G, San-Félix A, De Molina AR. Novel polyphenols that inhibit colon cancer cell growth affecting cancer cell metabolism. J Pharmacol Exp Ther. 2018;366:377–389. doi: 10.1124/jpet.118.248278. [DOI] [PubMed] [Google Scholar]
  44. Deng S, Chen SN, Yao P, Nikolic D, van Breemen RB, Bolton JL, Fong HH, Farnsworth NR, Pauli GF. Serotonergic activity-guided phytochemical investigation of the roots of Angelica s inensis. J Nat Prod. 2006;69:536–541. doi: 10.1021/np050301s. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Diaz-Roa A, Patarroyo MA, Bello FJ, Da Silva PI. Sarconesin: Sarconesiopsis magellanica blowfly larval excretions and secretions with antibacterial properties. Front Microbiol. 2018;9:2249. doi: 10.3389/fmicb.2018.02249. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Ding D, Guo YR, Wu RL, Qi WY, Xu HM. Two new isoquinoline alkaloids from Scolopendra subspinipes mutilans induce cell cycle arrest and apoptosis in human glioma cancer U87 cells. Fitoterapia. 2016;110:103–109. doi: 10.1016/j.fitote.2016.03.004. [DOI] [PubMed] [Google Scholar]
  47. D'orazio D, De Saizieu A, Schueler G, Raederstorff D, Teixeira S, Schmidt YW, Weber P, Wolfram S (2007) Use of phthalide derivatives for the treatment and prevention of diabetes mellitus. US Patent Application 10/556,199
  48. Douglas B. Science, voyages, and encounters in oceania, 1511–1850. Berlin: Springer; 2014. [Google Scholar]
  49. Dunn C, Raghavan U, Pfleiderer AG. The use of maggots in head and neck necrotizing fasciitis. J Laryngol Otol. 2002;116:70–72. doi: 10.1258/0022215021910212. [DOI] [PubMed] [Google Scholar]
  50. Feder M, Kalinowska I, Jaszczewska JA, Burchard E, Lewandowski W, Bulkowska U, Mazur M, Wos K (2015) Preparation of 1,1′,2,5′-tetrahydrospiro[indole-3,2′-pyrrole]-2,5′-dione derivatives useful as inhibitors of p53Mdm2 protein-protein interactions. PCT Int Appl WO 2015189799 A1 20151217
  51. Feng Y, Zhao M, He Z, Chen Z, Sun L. Research and utilization of medicinal insects in China. Entomol Res. 2009;39:313–316. doi: 10.1111/j.1748-5967.2009.00236.x. [DOI] [Google Scholar]
  52. Fleming A. On the antibacterial action of cultures of a Penicillium, with special reference to their use in the isolation of B. influenzae. Br J Exp Pathol. 1929;10:226. [PMC free article] [PubMed] [Google Scholar]
  53. Fonseca BM, Correia-da-Silva G, Teixeira NA. Cannabinoid-induced cell death in endometrial cancer cells: involvement of TRPV1 receptors in apoptosis. J Physiol Biochem. 2018;74:261–272. doi: 10.1007/s13105-018-0611-7. [DOI] [PubMed] [Google Scholar]
  54. Frost JW, Millis J, Tang Z (2010) Methods for producing dodecanedioic acid and derivatives thereof. PCT Int Appl WO 2010085712 A2 20100729
  55. Gaetani S, Oveisi F, Piomelli D. Modulation of meal pattern in the rat by the anorexic lipid mediator oleoylethanolamide. Neuropsychopharmacology. 2003;28:1311. doi: 10.1038/sj.npp.1300166. [DOI] [PubMed] [Google Scholar]
  56. Gao Y, Vlahakis JZ, Szarek WA, Brockhausen I. Selective inhibition of glycosyltransferases by bivalent imidazolium salts. Bioorg Med Chem. 2013;21:1305–1311. doi: 10.1016/j.bmc.2012.12.034. [DOI] [PubMed] [Google Scholar]
  57. Garneau-Tsodikova S, Shrestha SK, Garzan A, Chandrika NT (2018) Preparation of 1,2,4-triazole derivatives as antifungal agents. U.S. Pat Appl Publ US 20180194742 A1 20180712
  58. Geubelle P, Gilissen J, Dilly S, Poma L, Dupuis N, Laschet C, Abboud D, Inoue A, Jouret F, Pirotte B, Hanson J. Identification and pharmacological characterization of succinate receptor agonists. Br J Pharmacol. 2017;174:796–808. doi: 10.1111/bph.13738. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Giannini FA, Aimar ML, Sortino M, Gomez R, Sturniollo A, Juarez A, Zacchino S, de Rossi RH, Enriz RD. In vitro–in vivo antifungal evaluation and structure–activity relationships of 3H-1, 2-dithiole-3-thione derivatives. Farmaco. 2004;59:245–254. doi: 10.1016/j.farmac.2003.08.004. [DOI] [PubMed] [Google Scholar]
  60. Giuliani G, Paus R, Ramot Y, Becker A, Baroni S, Giuliani SA (2015) Compounds with a skin pigmenting activity and pharmaceutical or cosmetic compositions containing them. U.S. Patent 9,192,595
  61. Goldblum S, Warren CB (2018) Solavetivone and 5-epi-beta-vetivone as pest repellants and pesticides. U.S. Patent Application 15/837,830
  62. Gong W, Zhou Y, Li X, Gao X, Tian J, Qin X, Du G. Neuroprotective and cytotoxic phthalides from Angelicae Sinensis Radix. Molecules. 2016;21:549. doi: 10.3390/molecules21050549. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Gupta S, Ahmad H, Shukla B, Ojha N, Dwivedi AK. Isolation, structural characterization, and validation of a new compound present in non-carbonyl Curcuma longa (NCCL): a potential lead for stroke. J Heterocycl Chem. 2018;55:1926–1934. doi: 10.1002/jhet.3230. [DOI] [Google Scholar]
  64. Hakonarson H, Almogurea B, Vazquex LM, Sleiman PMA (2018) Identification of novel loci in asthma and methods of use thereof for the diagnosis and treatment of asthma. PCT Int Appl WO 2018018004 A1 20180125
  65. Hamidpour R, Hamidpour S, Hamidpour M, Sohraby M, Hamidpour M. Turmeric (Curcuma longa): from a variety of traditional medicinal application to its novel roles as active antioxidant, anti-inflammatory, anti-cancer, and anti-diabetes. Int J Pharmacol Phytochem Ethnomed. 2015;1:37–45. [Google Scholar]
  66. Hammond ML, Heck JV, Zambias RA (1992) Cyclic hexapeptides having antibiotic activity. Eur Pat Appl EP 500170 A2 19920826
  67. Harvey AL, Edrada-Ebel R, Quinn RJ. The re-emergence of natural products for drug discovery in the genomics era. Nat Rev Drug Discov. 2015;14:111. doi: 10.1038/nrd4510. [DOI] [PubMed] [Google Scholar]
  68. Hatamoto M, Aizawa R, Fukuchi T (2016) Fungicide composition for agriculture and horticulture. Jpn Kokai Tokkyo Koho JP 2016199526 A 20161201
  69. Hermes DJ, Xu C, Poklis JL, Niphakis MJ, Cravatt BF, Mackie K, Lichtman AH, Ignatowska-Jankowska BM, Fitting S. Neuroprotective effects of fatty acid amide hydrolase catabolic enzyme inhibition in a HIV-1 Tat model of neuroAIDS. Neuropharmacology. 2018;141:55–65. doi: 10.1016/j.neuropharm.2018.08.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Hirata H, Okawara B, Ono K, Akane M (2018) The therapeutic agent for lymphoedema comprising β2 simulant. Jpn Kokai Tokkyo Koho JP 2018108969 A 20180712
  71. Hyun TK, Eom SH, Kim JS. Molecular docking studies for discovery of plant-derived a-glucosidase inhibitors. Plant Omics. 2014;7:166. [Google Scholar]
  72. Ichihashi S, Okamura D (2017) Useful biocontrol composition having excellent pesticidal activity and biocontrol method using the same. Jpn. Kokai Tokkyo Koho JP 2017001958 A 20170105
  73. Ihori Y, Watanabe S, Inoue Shuuji, Kang CK, Shiinoki Y (2018) Preparation of guanidine compounds as agrochemical fungicides. PCT Int Appl WO 2018097126 A1 20180531
  74. Jarrott B, Williams SJ. Chronic brain inflammation: the neurochemical basis for drugs to reduce inflammation. Neurochem Res. 2016;41:523–533. doi: 10.1007/s11064-015-1661-7. [DOI] [PubMed] [Google Scholar]
  75. Jia Z, Zhu H, Li Y, Misra HP. Cruciferous nutraceutical 3H-1,2-dithiole-3-thione protects human primary astrocytes against neurocytotoxicity elicited by MPTP, MPP+, 6-OHDA, HNE and acrolein. Neurochem Res. 2009;34:1924–1934. doi: 10.1007/s11064-009-9978-8. [DOI] [PubMed] [Google Scholar]
  76. Johnson MR (2015) Chemically and metabolically stable dipeptide possessing potent sodium channel blocker activity. U.S. Patent 9,072,738
  77. Jung EB, Trinh TA, Lee TK, Yamabe N, Kang KS, Song JH, Choi S, Lee S, Jang TS, Kim KH, Hwang GS. Curcuzedoalide contributes to the cytotoxicity of Curcuma zedoaria rhizomes against human gastric cancer AGS cells through induction of apoptosis. J Ethnopharmacol. 2018;213:48–55. doi: 10.1016/j.jep.2017.10.025. [DOI] [PubMed] [Google Scholar]
  78. Just R, Demmer O, Giehm L, Villadsen JS, Munch HK, Skarbaliene J, Deryabina MA, Hamprecht DW, Mathiesen JM (2016) Amylin analogues and use thereof in treatment of disorders including obesity, excess food intake and associated metabolic diseases such as diabetes. PCT Int Appl WO 2016146739 A1 20160922
  79. Kacem N, Roumy V, Duhal N, Merouane F, Neut C, Christen P, Hostettmann K, Rhouati S. Chemical composition of the essential oil from Algerian Genista quadriflora Munby and determination of its antibacterial and antifungal activities. Ind Crops Prod. 2016;90:87–93. doi: 10.1016/j.indcrop.2016.06.016. [DOI] [Google Scholar]
  80. Kaneria MJ, Rakholiya KD, Marsonia LR, Dave RA, Golakiya BA. Nontargeted metabolomics approach to determine metabolites profile and antioxidant study of Tropical Almond (Terminalia catappa L.) fruit peels using GC-QTOF-MS and LC-QTOF-MS. J Pharm Biomed Anal. 2018;160:415–427. doi: 10.1016/j.jpba.2018.08.026. [DOI] [PubMed] [Google Scholar]
  81. Keglevich G. Green synthetic approaches for biologically relevant heterocycles. Amsterdam: Elsevier; 2015. Application of microwave irradiation in the synthesis of P-heterocycles; pp. 559–570. [Google Scholar]
  82. Khan NA, Siddiqui R. Acanthamoeba affects the integrity of human brain microvascular endothelial cells and degrades the tight junction proteins. Int J Parasitol. 2009;39:1611–1616. doi: 10.1016/j.ijpara.2009.06.004. [DOI] [PubMed] [Google Scholar]
  83. Khan NA, Osman K, Goldsworthy GJ. Lysates of Locusta migratoria brain exhibit potent broad-spectrum antibacterial activity. J Antimicrob Chemother. 2008;62:634–635. doi: 10.1093/jac/dkn239. [DOI] [PubMed] [Google Scholar]
  84. Kharkwala GC, Pandea C, Tewari G, Panwarb A, Pandeb V. Terpenoid composition and antimicrobial activity of essential oil from Torilis japonica (Houtt.) DC. J Indian Chem Soc. 2017;94:191–194. [Google Scholar]
  85. Kim SG, Ki SH, Hwang SH (2016) Pharmaceutical composition containing 1,2-dithiolthione derivative for preventing or treating disease caused by overexpression of LXR-α. U.S. Patent 9,370,504
  86. Klein LL, Li L, Chen HJ, Curty CB, DeGoey DA, Grampovnik DJ, Leone CL, Thomas SA, Yeung CM, Funk KW, Kishore V. Total synthesis and antifungal evaluation of cyclic aminohexapeptides. Bioorg Med Chem. 2000;8:1677–1696. doi: 10.1016/S0968-0896(00)00097-3. [DOI] [PubMed] [Google Scholar]
  87. Komorowska-kulik J, Ptaszkowska J, Turos-biernacka M, Koperska M, Laszcz E, Zielinski J (1998) Fungicidal agent. Pol PL 175313 B1 19981231
  88. Koo JH, Lee WH, Lee CG, Kim SG. Fyn inhibition by cycloalkane-fused 1,2-dithiole-3-thiones enhances antioxidant capacity and protects mitochondria from oxidative injury. Mol Pharmacol. 2012;82:27–36. doi: 10.1124/mol.111.077149. [DOI] [PubMed] [Google Scholar]
  89. Ksouri A, Dob T, Belkebir A, Dahmane D, Nouasri A. Volatile compounds and biological activities of aerial parts of Pituranthos scoparius (Coss and Dur) Schinz (Apiaceae) from Hoggar, southern Algeria. Trop J Pharm Res. 2017;16:51–58. doi: 10.4314/tjpr.v16i1.7. [DOI] [Google Scholar]
  90. Kuo PC, Brown DA, Scofield BA, Yu IC, Chang FL, Wang PY, Yen JH. 3H-1, 2-dithiole-3-thione as a novel therapeutic agent for the treatment of experimental autoimmune encephalomyelitis. Brain Behav Immun. 2016;57:173–186. doi: 10.1016/j.bbi.2016.03.015. [DOI] [PubMed] [Google Scholar]
  91. Kuo PC, Yu IC, Scofield BA, Brown DA, Curfman ET, Paraiso HC, Chang FL, Yen JH. 3H-1,2-Dithiole-3-thione as a novel therapeutic agent for the treatment of ischemic stroke through Nrf2 defense pathway. Brain Behav Immun. 2017;62:180–192. doi: 10.1016/j.bbi.2017.01.018. [DOI] [PubMed] [Google Scholar]
  92. Kwak MK, Itoh K, Yamamoto M, Sutter TR, Kensler TW. Role of transcription factor Nrf2 in the induction of hepatic phase 2 and antioxidative enzymes in vivo by the cancer chemoprotective agent, 3H-1,2-dimethiole-3-thione. Mol Med. 2001;7:135. doi: 10.1007/BF03401947. [DOI] [PMC free article] [PubMed] [Google Scholar]
  93. Lee S, Duce I, Atkins H, Khan NA. Cockroaches and locusts: physicians’ answer to infectious diseases. Int J Antimicrob Agents. 2011;37:279. doi: 10.1016/j.ijantimicag.2010.12.005. [DOI] [PubMed] [Google Scholar]
  94. Lee GJ, Kim YH, Kim HJ, Lee HY, Jung SW, Jung JE, Seo EG (2013) Preparation of UCH-L1 inhibitor. Repub Korean Kongkae Taeho Kongbo KR 2013112519 A 20131014
  95. Lee KJ, Kim Y, Kim HJ, Lee HY, Joung S, J JE, Seo EK (2014) Preparation of benzene derivatives as UCH-L1 inhibitors. PCT Int Appl WO 2014185561 A1 20141120
  96. Lee IS, Uh I, Kim KS, Kim KH, Park J, Kim Y, Jung JH, Jang HJ. Anti-inflammatory effects of ginsenoside Rg3 via NF-κB pathway in A549 cells and human asthmatic lung tissue. J Immunol Res. 2016;2016:1–11. doi: 10.1155/2016/7521601. [DOI] [PMC free article] [PubMed] [Google Scholar]
  97. Lee JH, Kim IW, Kim MA, Ahn MY, Yun EY, Hwang JS. Antimicrobial activity of the scolopendrasin V peptide identified from the centipede Scolopendra subspinipes mutilans. J Microbiol Biotechnol. 2017;27:43–48. doi: 10.4014/jmb.1609.09057. [DOI] [PubMed] [Google Scholar]
  98. Lee TK, Trinh TA, Lee SR, Kim S, So HM, Moon E, Hwang GS, Kang KS, Kim JH, Yamabe N, Kim KH. Bioactivity-based analysis and chemical characterization of anti-inflammatory compounds from Curcuma zedoaria rhizomes using LPS-stimulated RAW264.7 cells. Bioorg Chem. 2019;82:26–32. doi: 10.1016/j.bioorg.2018.09.027. [DOI] [PubMed] [Google Scholar]
  99. Lei W, Ni J, Xia X, Jiang M, Bai G. Searching for synergistic calcium antagonists and novel therapeutic regimens for coronary heart disease therapy from a Traditional Chinese Medicine, Suxiao Jiuxin Pill. J Chromatogr B. 2018;1092:220–227. doi: 10.1016/j.jchromb.2018.06.015. [DOI] [PubMed] [Google Scholar]
  100. Li S, Shi H, Chang W, Li Y, Zhang M, Qiao Y, Lou H. Eudesmane sesquiterpenes from Chinese liverwort are substrates of Cdrs and display antifungal activity by targeting Erg6 and Erg11 of Candida albicans. Bioorg Med Chem. 2017;25:5764–5771. doi: 10.1016/j.bmc.2017.09.001. [DOI] [PubMed] [Google Scholar]
  101. Lim HS, Yo SR, Lee MY, Seo CS, Shin HK, Jeong SJ. Potential inhibitory effects of the traditional herbal prescription Hyangso-san against skin inflammation via inhibition of chemokine production and inactivation of STAT1 in HaCaT keratinocytes. Mol Med Rep. 2018;17:2515–2522. doi: 10.3892/mmr.2017.8172. [DOI] [PubMed] [Google Scholar]
  102. Liu X, Cao A, Ouyang C, Li Y, Yan D, Wang Q, Guo M (2015) Fungicide containing Eupatorium adenophora extract and mancozeb. Faming Zhuanli Shenqing CN 105123721 A 20151209
  103. Liu X, Cao A, Ouyang C, Li Y, Yan D, Wang Q, Guo M (2016) A compound fungicide containing Ageratina adenophora extract and iprodione. Faming Zhuanli Shenqing CN 105532707 A 20160504
  104. Lu-Si L, Cheng P, Qin-Mei Z, Xiong L, Guo L, Wang YN, Dai O. Effects of Angelica oil and the isolated butylphthalides on glutamate-induced neurotoxicity in PC12 cells. Rec Nat Prod. 2017;11:217. [Google Scholar]
  105. Macegoniuk K, Kowalczyk R, Rudzińska A, Psurski M, Wietrzyk J, Berlicki Ł. Potent covalent inhibitors of bacterial urease identified by activity–reactivity profiling. Bioorg Med Chem Lett. 2017;27:1346–1350. doi: 10.1016/j.bmcl.2017.02.022. [DOI] [PubMed] [Google Scholar]
  106. Maiwald A, Hammami M, Wagner S, Heine A, Klebe G, Steinmetzer T. Changing the selectivity profile—from substrate analog inhibitors of thrombin and factor Xa to potent matriptase inhibitors. J Enzyme Inhib Med Chem. 2016;31:89–97. doi: 10.3109/14756366.2016.1172574. [DOI] [PubMed] [Google Scholar]
  107. Martin A (2018) Compositions and methods for the treatment and prevention of chronic hypoxemia and dyspnea. U.S. Patent Application 15/441,552
  108. Matsunaga S, Myamae Y, Mukoyama K (1996) Bleaching detergent compositions showing good perfume fragrance retention. Jpn Kokai Tokkyo Koho JP 08218094 A 19960827
  109. Maya SP, Beltrán DD, Lemercier P, Leiva-Salinas C. Necrotizing fasciitis: an urgent diagnosis. Skeletal Radiol. 2014;43:577–589. doi: 10.1007/s00256-013-1813-2. [DOI] [PubMed] [Google Scholar]
  110. Mehner C, Müller D, Krick A, Kehraus S, Löser R, Gütschow M, Maier A, Fiebig HH, Brun R, König GM. A novel β-amino acid in cytotoxic peptides from the cyanobacterium Tychonema sp. Eur J Org Chem. 2008;2008:1732–1739. doi: 10.1002/ejoc.200701033. [DOI] [Google Scholar]
  111. Mérillon JM, Rivière C. Natural antimicrobial agents. Berlin: Springer; 2018. pp. 1–342. [Google Scholar]
  112. Migahed MA, El-kousy SM, Tayel RF, Zaki EG. Synthesis, characterization, surface active properties, biological activity of ethoxylated dodecyl benzenesulfonamide. J Pharm Biol Chem Sci. 2017;8:1967. [Google Scholar]
  113. Mitchard M (1988) Sulphur compounds used in medicine, vol 6, pp 183–202 [DOI] [PubMed]
  114. Mo EJ, Yang HJ, Jeong JY, Kim SB, Liu Q, Hwang BY, Lee MK. Pancreatic lipase inhibitory phthalide derivatives from the rhizome of Cnidium officinale. Rec Nat Prod. 2016;10:148. [Google Scholar]
  115. Mohamede ASI, Elneairy MAA, Eldine SM. 2,4-Cycloaddition reactions: preparation and cytotoxicity of novel quinoline and pyrrolo [3,4-f]quinoline derivatives. Int J Pharm Pharm Sci. 2015;7:64–68. [Google Scholar]
  116. Moon SS, Cho N, Shin J, Seo Y, Lee CO, Choi SU. Jineol, a cytotoxic alkaloid from the centipede Scolopendra subspinipes. J Nat Prod. 1996;59:777–779. doi: 10.1021/np960188t. [DOI] [Google Scholar]
  117. Nawamaki K, Kuroyanagi M. Sesquiterpenoids from Acorus calamus as germination inhibitors. Phytochemistry. 1996;43:1175–1182. doi: 10.1016/S0031-9422(96)00401-3. [DOI] [Google Scholar]
  118. Negi PS, Jayaprakasha GK, Jagan Mohan Rao L, Sakariah KK. Antibacterial activity of turmeric oil: a byproduct from curcumin manufacture. J Agric Food Chem. 1999;47:4297–4300. doi: 10.1021/jf990308d. [DOI] [PubMed] [Google Scholar]
  119. Newton GGF, Abraham EP. Cephalosporin C, a new antibiotic containing sulphur and d-a-aminoadipic acid. Nature. 1955;175:548. doi: 10.1038/175548a0. [DOI] [PubMed] [Google Scholar]
  120. Nigam Y, Dudley E, Bexfield A, Bond AE, Evans J, James J. The physiology of wound healing by the medicinal maggot, Lucilia sericata. Adv In Insect Phys. 2010;39:39–81. doi: 10.1016/B978-0-12-381387-9.00002-6. [DOI] [Google Scholar]
  121. Niu Y, Wang M, Cao Y, Nimmagadda A, Hu J, Wu Y, Cai J, Ye XS. Rational design of dimeric lysine N-alkylamides as potent and broad-spectrum antibacterial agents. J Med Chem. 2018;61:2865–2874. doi: 10.1021/acs.jmedchem.7b01704. [DOI] [PubMed] [Google Scholar]
  122. Nomura A, Kachi H, Matsuzawa M, Tokura H, Komori M (2016) Water-based cosmetic containing agar, xanthan gum and water-soluble polymer. PCT Int Appl WO 2016143663 A1 20160915
  123. Ooi CC, Good NM, Williams DB, Lewanowitsch T, Cosgrove LJ, Lockett TJ, Head RJ. Efficacy of butyrate analogues in HT-29 cancer cells. Clin Exp Pharmacol Physiol. 2010;37:482–489. doi: 10.1111/j.1440-1681.2009.05335.x. [DOI] [PubMed] [Google Scholar]
  124. Or YS (1997) Preparation of tricyclic erythromycins as bactericides. WO 9717356
  125. Pagano E, Borrelli F, Orlando P, Romano B, Monti M, Morbidelli L, Aviello G, Imperatore R, Capasso R, Piscitelli F, Buono L. Pharmacological inhibition of MAGL attenuates experimental colon carcinogenesis. Pharmacol Res. 2017;119:227–236. doi: 10.1016/j.phrs.2017.02.002. [DOI] [PubMed] [Google Scholar]
  126. Pandey P, Chaurasiya ND, Tekwani BL, Doerksen RJ. Interactions of endocannabinoid virodhamine and related analogs with human monoamine oxidase-A and-B. Biochem Pharmacol. 2018;155:82–91. doi: 10.1016/j.bcp.2018.06.024. [DOI] [PMC free article] [PubMed] [Google Scholar]
  127. Park SC, Park JU, Yoo CY, Oh SY, Lee ED, Park JH, Park CU (2018) A composition for controlling nematodes containing an alkylamine and a fatty acid. Repub Korea KR 1827442 B1 20180208
  128. Pascal RA, Jr, Oliver MA, Chen YJ. Alternate substrates and inhibitors of bacterial 4-hydroxyphenylpyruvate dioxygenase. Biochemistry. 1985;24:3158–3165. doi: 10.1021/bi00334a013. [DOI] [PubMed] [Google Scholar]
  129. Pelcman B, Bengtsson T (2018) Combinations of adrenergic receptor agonists for the treatment of type 2 diabetes. PCT Int Appl WO 2018011588 A1 20180118
  130. Peng K, Kong Y, Zhai L, Wu X, Jia P, Liu J, Yu H. Two novel antimicrobial peptides from centipede venoms. Toxicon. 2010;55:274–279. doi: 10.1016/j.toxicon.2009.07.040. [DOI] [PubMed] [Google Scholar]
  131. Perez-Leal O, Barrero CA, Merali S. Pharmacological stimulation of nuclear factor (erythroid-derived 2)-like 2 translation activates antioxidant responses. J Biol Chem. 2017;292:14108–14121. doi: 10.1074/jbc.M116.770925. [DOI] [PMC free article] [PubMed] [Google Scholar]
  132. Petrov AD, Nikishin GI, Nevolin FV, Kral-Osikina GA, Orekhova MV, Yushkevich AV. Dependence of surface-active and detergent properties of alkylbenzenesulfonates on the length and structure of the alkyl chain. Masloboino-Zhirovaya Promyshlennost. 1958;24:23–29. [Google Scholar]
  133. Preston D, Murphy RB (2015) Antiviral epicatechins, epicatechin oligomers, or thiolated epicatechins from theobroma cacao for treatment of genital warts. U.S. Patent Application 14/202,103
  134. Rock EM, Moreno-Sanz G, Limebeer CL, Petrie GN, Angelini R, Piomelli D, Parker LA. Suppression of acute and anticipatory nausea by peripherally restricted fatty acid amide hydrolase inhibitor in animal models: role of PPARα and CB1 receptors. Br J Pharmacol. 2017;174:3837–3847. doi: 10.1111/bph.13980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  135. Rojewska M, Biadasz A, Kotkowiak M, Olejnik A, Rychlik J, Dudkowiak A, Prochaska K. Adsorption properties of biologically active derivatives of quaternary ammonium surfactants and their mixtures at aqueous/air interface. I. Equilibrium surface tension, surfactant aggregation and wettability. Colloids Surf B Biointerfaces. 2013;110:387–394. doi: 10.1016/j.colsurfb.2013.05.009. [DOI] [PubMed] [Google Scholar]
  136. Sato M (2016) Aerosol type deodorant composition containing hydrophilic powder and dicarboxylate-based deodorant. Jpn Kokai Tokkyo Koho JP 2016000719 A 20160107
  137. Savage Paul B (2017) Preparation of cationic steroidal antimicrobials for treating bacterial infections. Pat Appl Publ US 20170210776 A1 20170727
  138. Scherzer C (2018) Combinations including beta-adrenoreceptor agonists for treatment of Parkinson’s disease and movement disorders. PCT Int Appl WO 2018195473 A1 20181025
  139. Science daily (2011) World population to surpass 7 billion in 2011; explosive population growth means challenges for developing nations https://www.sciencedaily.com/releases/2011/07/110728144933.htm. Accessed 10 June 2019
  140. Smith T. Antibiotics from soil bacteria. Nat Struct Mol Biol. 2000;7:189–190. doi: 10.1038/73283. [DOI] [PubMed] [Google Scholar]
  141. Sofian FF, Tamba L, Susilawati Y, Runadi D, Tjitraresmi A, Ramadhania ZM, Wardojo MM. Larvicidal activity of Curcuma heyneana Val. & v. Zijp rhizome against Aedes aegypti larvae. Res J Pharm Biol Chem Sci. 2017;8:80–88. [Google Scholar]
  142. Srivastava SK, Babu N, Pandey H (2009) Traditional insect bioprospecting—as human food and medicine
  143. Stewart GR, Maher C, Gay B, Andresen JM, Fox M, Goldstein D, Petrou S, Petrovski S (2018) Methods of treating epilepsy and voltage-gated potassium channels KCNQ2 related conditions. PCT Int Appl WO 2018204765 A1 20181108
  144. Stojakowska A, Galanty A, Malarz J, Michalik M. Major terpenoids from Telekia speciosa flowers and their cytotoxic activity in vitro. Nat Prod Res. 2019;33:1804–1808. doi: 10.1080/14786419.2018.1437431. [DOI] [PubMed] [Google Scholar]
  145. Stürzebecher J, Steinmetzer T, Schweinitz A, Stürzebecher A, Dönnecke D (2015) Base-substituted benzylamine analogs for use as coagulation factor Xa inhibitors, the production and use thereof. U.S. Patent 9,090,658
  146. Surolia A, Gautam RK, Dwivedi VK, Gupta S (2014) Synthetic peptides and random copolymers for the treatment of autoimmune disorders. U.S. Pat Appl Publ US 20140348861 A1 20141127
  147. Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Monnet DL, Pulcini C, Kahlmeter G, Kluytmans J, Carmeli Y, Ouellette M. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis. 2018;18:318–327. doi: 10.1016/S1473-3099(17)30753-3. [DOI] [PubMed] [Google Scholar]
  148. Tanwar B, Kumar A, Yogeeswari P, Sriram D, Chakraborti AK. Design, development of new synthetic methodology, and biological evaluation of substituted quinolines as new anti-tubercular leads. Bioorg Med Chem Lett. 2016;26:5960–5966. doi: 10.1016/j.bmcl.2016.10.082. [DOI] [PubMed] [Google Scholar]
  149. Toguri JT, Leishman E, Szczesniak AM, Laprairie RB, Oehler O, Straiker AJ, Kelly MEM, Bradshaw HB. Inflammation and CB2 signaling drive novel changes in the ocular lipidome and regulate immune cell activity in the eye. Prostaglandins Other Lipid Mediat. 2018;139:54–62. doi: 10.1016/j.prostaglandins.2018.09.004. [DOI] [PubMed] [Google Scholar]
  150. Tran QT, Xu L, Phan V, Goodwin SB, Rahman M, Jin VX, Sutter CH, Roebuck BD, Kensler TW, George EO, Sutter TR. Chemical genomics of cancer chemopreventive dithiolethiones. Carcinogenesis. 2009;30:480–486. doi: 10.1093/carcin/bgn292. [DOI] [PMC free article] [PubMed] [Google Scholar]
  151. Tran HNK, Cao TQ, Kim JA, Youn UJ, Kim S, Woo MH, Min BS. Anti-inflammatory activity of compounds from the rhizome of Cnidium officinale. Arch Pharm Res. 2018;41:977–985. doi: 10.1007/s12272-018-1048-9. [DOI] [PubMed] [Google Scholar]
  152. Undheim EA, King GF. On the venom system of centipedes (Chilopoda), a neglected group of venomous animals. Toxicon. 2011;57:512–524. doi: 10.1016/j.toxicon.2011.01.004. [DOI] [PubMed] [Google Scholar]
  153. Vosátka R, Krátký M, Švarcová M, Janoušek J, Stolaříková J, Madacki J, Huszár S, Mikušová K, Korduláková J, Trejtnar F, Vinšová J. New lipophilic isoniazid derivatives and their 1,3,4-oxadiazole analogues: synthesis, antimycobacterial activity and investigation of their mechanism of action. Eur J Med Chem. 2018;151:824–835. doi: 10.1016/j.ejmech.2018.04.017. [DOI] [PubMed] [Google Scholar]
  154. Wagman GH. Antibiotics from Micromonospora. Annu Rev Microbiol. 1980;34:537–558. doi: 10.1146/annurev.mi.34.100180.002541. [DOI] [PubMed] [Google Scholar]
  155. Wang CC, Chen WR (2017) Method for preventing cancer by using phthalides. U.S. Patent Application 15/071,190
  156. Wang C, Li J, Yang R, Zhao Y, Cheng Y, Zhang Z, He L. Petasins from the rhizomes of Ligularia fischeri and its derivatives. Rec Nat Prod. 2014;8:156. [Google Scholar]
  157. Wang L, Wang M, Hu J, Shen W, Hu J, Yao Y, Wang X, Afzal CM, Ma R, Li G. Protective effect of 3H-1, 2-dithiole-3-thione on cellular model of Alzheimer’s disease involves Nrf2/ARE signaling pathway. Eur J Pharmacol. 2017;795:115–123. doi: 10.1016/j.ejphar.2016.12.013. [DOI] [PubMed] [Google Scholar]
  158. Wang N, Zhang Q, Xin H, Shou D, Qin L. Osteoblast cell membrane chromatography coupled with liquid chromatography and time-of-flight mass spectrometry for screening specific active components from traditional Chinese medicines. J Sep Sci. 2017;40:4311–4319. doi: 10.1002/jssc.201700688. [DOI] [PubMed] [Google Scholar]
  159. Wang J, Wu J, Li X, Liu H, Qin J, Bai Z, Chi B, Chen X. Identification and validation nucleolin as a target of curcumol in nasopharyngeal carcinoma cells. J Proteomics. 2018;182:1–11. doi: 10.1016/j.jprot.2018.04.025. [DOI] [PubMed] [Google Scholar]
  160. Wang JJ, Yakatan GJ, Lin TN, Gao JH (2018b) Pharmaceutical compositions and methods of treating cardiovascular diseases. U.S. Patent Application 15/973,132
  161. Wang MM, Chu WC, Yang Y, Yang QQ, Qin SS, Zhang E. Dithiocarbamates: efficient metallo-β-lactamase inhibitors with good antibacterial activity when combined with meropenem. Bioorg Med Chem Lett. 2018;28:3436–3440. doi: 10.1016/j.bmcl.2018.09.028. [DOI] [PubMed] [Google Scholar]
  162. Weinstein E, Mata-Fink J, Kahvejian A, Afeyan NB, Jeanbart LK, Lantermann A, Hurov JB (2018) Neuromodulating compositions and related therapeutic methods for the treatment of cancer. PCT Int Appl WO 2018022668 A2 20180201
  163. Wenhua R, Shuangquan Z, Daxiang S, Kaiya Z, Guang Y. Induction, purification and characterization of an antibacterial peptide scolopendrin I from the venom of centipede Scolopendra subspinipes mutilans. Indian J Biochem Biophys. 2006;43:88–93. [PubMed] [Google Scholar]
  164. Wisetsai A, Lekphrom R, Schevenels FT. A novel cyclohexenone from Trachyspermum roxburghianum. Nat Prod Res. 2018;32:2499–2504. doi: 10.1080/14786419.2017.1423299. [DOI] [PubMed] [Google Scholar]
  165. Wortley MA, Adcock JJ, Dubuis ED, Maher SA, Bonvini SJ, Delescluse I, Kinloch R, McMurray G, Perros-Huguet C, Papakosta M, Birrell MA. Targeting fatty acid amide hydrolase as a therapeutic strategy for antitussive therapy. Eur Respir J. 2017;50:1700782. doi: 10.1183/13993003.00782-2017. [DOI] [PubMed] [Google Scholar]
  166. Wrasidlo W, Natala SR (2018) Lipid-substituted amino 1,2-and 1,3-diol compounds as modulators of TLR2 dimerization. PCT Int Appl WO 2018026866 A1 20180208
  167. Wu P, Liu S, Su J, Chen J, Li L, Zhang R, Chen T. Apoptosis triggered by isoquercitrin in bladder cancer cells by activating the AMPK-activated protein kinase pathway. Food Funct. 2017;8:3707–3722. doi: 10.1039/C7FO00778G. [DOI] [PubMed] [Google Scholar]
  168. Xu J, Zeng GZ, Liu YM, Chen KL, Sun ZH, Zhang YM, Tan NH. Sesquiterpenoids and diterpenes from Chamaecyparis obtusa var. breviramea f. crippsii. Zeitschrift für Naturforschung B. 2014;69:362–368. doi: 10.5560/znb.2014-3243. [DOI] [Google Scholar]
  169. Xu J, Zhu HL, Zhang J, Du T, Guo EY, Liu WY, Luo JG, Ye F, Feng F, Qu W. Sesquiterpenoids from Chloranthus anhuiensis with neuroprotective effects in PC12 cells. J Nat Prod. 2018;81:1391–1398. doi: 10.1021/acs.jnatprod.7b01076. [DOI] [PubMed] [Google Scholar]
  170. Zambias RA, Hammond ML, Heck JV, Bartizal K, Trainor C, Abruzzo G, Schmatz DM, Nollstadt KM. Preparation and structure-activity relationships of simplified analogs of the antifungal agent cilofungin: a total synthesis approach. J Med Chem. 1992;35:2843–2855. doi: 10.1021/jm00093a018. [DOI] [PubMed] [Google Scholar]
  171. Zhang F, Qi P, Xue R, Li Z, Zhu K, Wan P, Huang C. Qualitative and quantitative analysis of the major constituents in Acorus tatarinowii Schott by HPLC/ESI-QTOF-MS/MS. Biomed Chromatogr. 2015;29:890–901. doi: 10.1002/bmc.3371. [DOI] [PubMed] [Google Scholar]
  172. Zhang C, Xie L, Guan F, Cui Y. 3H-1, 2-dithiole-3-thione protects PC12 cells against amyloid beta 1–42 (Aβ1–42) induced apoptosis via activation of the ERK1/2 pathway. Life Sci. 2018;213:74–81. doi: 10.1016/j.lfs.2018.10.025. [DOI] [PubMed] [Google Scholar]
  173. Zhang YQ, Guo QY, Li QY, Ren WQ, Tang SH, Wang SS, Liang RX, Li DF, Zhang Y, Xu HY, Yang HJ. Main active constituent identification in Guanxinjing capsule, a traditional Chinese medicine, for the treatment of coronary heart disease complicated with depression. Acta Pharmacol Sin. 2018;39:975. doi: 10.1038/aps.2017.117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  174. Zhao RY, Yang Q, Huang Y, Gai S, Zhao L, Ye H, Guo H, Tong Q, Cao M, Jia J, Yang C, Li W, Zhou X, Xie H, Lin C, Guo Z, Ye Z (2016) Preparation of specific conjugation bridge linkers and immunoconjugates and methods of using them. PCT Int Appl WO 2016059622 A2 20160421
  175. Zhao RY, Yang Q, Huang Y, Gai S, Ye H, Yang C, Guo H, Zhou X, Xie H, Tong Q, Minjun C, Linyao Z, Junxiang J, Wenjun L, Xiaotao Z, Chen L, Yifang X, Zixiang G (2017) Preparation of derivatives of amanita toxins and their conjugation to a cell binding molecule as targeted therapeutic agents. PCT Int Appl WO 2017046658 A1 20170323
  176. Zhao YR, Yang Q, Huang Y, Gai S, Ye H, Zhao L, Yang C, Guo H, Zhou X, Xie H, Zhu H, Xu Y, Tong Q, Jia J, Cao M, Li W, Gao S, Guo Z, Bai L, Li C, Yang Y, Wang C, Ye Z (2018) Conjugation linkers, cell binding molecule-drug conjugates containing the peptide linkers, methods of making and uses such conjugates with the linkers. PCT Int Appl WO 2018086139 A1 20180517
  177. Zubrzycki M, Janecka A, Liebold A, Ziegler M, Zubrzycka M. Effects of centrally administered endocannabinoids and opioids on orofacial pain perception in rats. Br J Pharmacol. 2017;174:3780–3789. doi: 10.1111/bph.13970. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

All the data analysed in this study are included in this article.


Articles from AMB Express are provided here courtesy of Springer-Verlag

RESOURCES